Table 2.
Risk of mortality and complications due to hyperglycemia in patients receiving PN.
| Study | Cheung (2005) | Lin (2007) | Sarkisian (2009) | Pasquel (2009) |
|---|---|---|---|---|
| Hyperglycemia(mmol/L) | >9.1* | >10** | >10*** | >10**** |
| Mortality OR(95%CI) | 10.90(2.0 − 60.5)X | 5.0(2.4 − 10.6)X | 7.22(1.08 − 48.3)X | 2.80(1.20 − 6.80)X |
| Any Infection OR(95%CI) | 3.9(1.2 − 12.0)X | 3.1(1.5 − 6.5)X | 0.9(0.3−2.5) | NA |
| Cardiac OR(95%CI) | 6.2(0.7−57.8) | 1.6(0.3-7.2) | 1.3(0.1−12.5) | NA |
| Acute Renal Failure OR(95%CI) | 10.9(1.2 − 98.1)X | 3.0(1.2 − 7.7)X | 1.9(0.4−8.6) | 2.2(1.0−4.8) |
| Septicemia OR(95%CI) | 2.5(0.7−9.3) | NA | NA | NA |
| Any Complication OR(95%CI) | 4.3(1.4 − 13.1)X | 5.5(2.5 − 12.4)X | NA | NA |
All study results are adjusted for age and sex.
X Significant at P < .05.
*ORs are expressed using blood glucose <6.9 mmol/L as a reference category.
**ORs are expressed using blood glucose <6.3 mmol/L as a reference category.
***ORs are expressed using blood glucose <10 mmol/L as a reference category.
****ORs are expressed using blood glucose <6.7 mmol/L as a reference category as measured within 24 hours of PN initiation.